Analysts at Bank of America (BAC) downgraded their rating on the shares of Bio-Reference Laboratories Inc. (BRLI) to ‘Underperform’ from ‘Buy’ in a research report issued to clients and investors on Thursday. The target price has been lowered to $32.00/share. Bio-Reference Laboratories shares closed at $32.60 yesterday. The firm’s target price suggests a potential upside […]
View the full post at: Notable Downgrades: Bio-Reference Lab (BRLI), Visa Inc (V), Whole Foods Market (WFM), GT Advanced Tech (GTAT), Lululemon Athletica (LULU)